Related Experiment Video
Updated: Dec 7, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
P2Y2R contributes to the development of diabetic nephropathy by inhibiting autophagy response
Theodomir Dusabimana1, So Ra Kim2, Eun Jung Park2
1Department of Pharmacology, Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju 52727, Republic of Korea; Department of Convergence Medical Sciences, Institute of Health Sciences, Gyeongsang National University Graduate School, Jinju 52727, Republic of Korea.
Objective:
Diabetic nephropathy (DN) is one of the most common complications of diabetes and a critical risk factor for developing end-stage renal disease. Activation of purinergic receptors, including P2Y2R has been associated with the pathogenesis of renal diseases, such as polycystic kidney and glomerulonephritis. However, the role of P2Y2R and its precise mechanisms in DN remain unknown. We hypothesised that P2Y2R deficiency may play a protective role in DN by modulating the autophagy signalling pathway.
Methods:
We used a mouse model of DN by combining a treatment of high-fat diet and streptozotocin after unilateral nephrectomy in wild-type or P2Y2R knockout mice. We measured renal functional parameter in plasma, examined renal histology, and analysed expression of autophagy regulatory proteins.
Results:
Hyperglycaemia and ATP release were induced in wild type-DN mice and positively correlated with renal dysfunction. Conversely, P2Y2R knockout markedly attenuates albuminuria, podocyte loss, development of glomerulopathy, renal tubular injury, apoptosis and interstitial fibrosis induced by DN. These protective effects were associated with inhibition of AKT-mediated FOXO3a (forkhead box O3a) phosphorylation and induction of FOXO3a-induced autophagy gene transcription. Furthermore, inhibitory phosphorylation of ULK-1 was decreased, and the downstream Beclin-1 autophagy signalling was activated in P2Y2R deficiency. Increased SIRT-1 (sirtuin-1) and FOXO3a expression in P2Y2R deficiency also enhanced autophagy response, thereby ameliorating renal dysfunction in DN.
Conclusions:
P2Y2R contributes to the pathogenesis of DN by impairing autophagy and serves as a therapeutic target for treating DN.
Insights
Mice lacking P2Y2R showed reduced kidney damage in diabetic nephropathy (DN). This protective effect was linked to improved autophagy, suggesting P2Y2R as a potential therapeutic target for DN.
Area of Science:
- Nephrology
- Molecular Biology
- Cellular Biology
Background:
- Diabetic nephropathy (DN) is a major complication of diabetes, leading to end-stage renal disease.
- Purinergic receptors, like P2Y2R, are implicated in kidney diseases, but their role in DN is unclear.
- Autophagy dysregulation is observed in DN, suggesting its involvement in disease progression.
Purpose of the Study:
- To investigate the role of P2Y2R in the pathogenesis of diabetic nephropathy (DN).
- To determine if P2Y2R deficiency offers protection against DN by modulating autophagy.
- To elucidate the underlying molecular mechanisms of P2Y2R's involvement in DN.
Main Methods:
- A mouse model of DN was established using a high-fat diet and streptozotocin in wild-type and P2Y2R knockout mice.
- Renal function was assessed via plasma parameters, and renal histology was examined.
- Expression levels of autophagy regulatory proteins were analyzed.
Main Results:
- P2Y2R knockout mice exhibited significantly reduced albuminuria, podocyte loss, glomerulopathy, tubular injury, apoptosis, and fibrosis in DN.
- DN induced hyperglycemia and ATP release correlated with renal dysfunction in wild-type mice.
- P2Y2R deficiency preserved renal function by inhibiting AKT-mediated FOXO3a phosphorylation, promoting autophagy gene transcription, decreasing ULK-1 phosphorylation, and activating Beclin-1 signaling.
Conclusions:
- P2Y2R plays a detrimental role in diabetic nephropathy (DN) by impairing autophagy.
- P2Y2R deficiency confers protection against DN through enhanced autophagy.
- P2Y2R represents a potential therapeutic target for managing DN.
More Related Videos
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Related Concept Videos
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
cAMP-dependent Protein Kinase Pathways